Nationwide, an estimated 1.4 million such women get potentially
unnecessary pelvic exams and an estimated 1.6 million get cervical
cancer screenings they may not need, researchers report in JAMA
Internal Medicine.
Needless tests "can lead to false alarms, unnecessary treatment, and
needless cost," said study leader Jin Qin of the U.S. Centers for
Disease Control and Prevention in Atlanta.
"Many young women associate the examination with fear, anxiety,
embarrassment, discomfort and pain," and some of them "may forgo
contraception or sexually transmitted infection (STI) screening
because of psychological stress associated with these exams, which
could lead to unintended pregnancies and may increase overall health
risks, "Qin said by email.
Cervical cancer screening, done by placing an instrument into the
vagina to scrape cells from the cervix, isn't recommended for women
under 21 under guidelines from the U.S. Preventive Services Task
Force, the American College of Obstetricians and Gynecologists and
the American Cancer Society.
Pelvic exams, which typically involve inserting a speculum to widen
the vagina and visually examine the cervix as well as a manual
internal exam of the reproductive organs and rectum, aren't
recommended for asymptomatic women who aren't pregnant.
Young women and parents of teens should know that prescribing most
contraceptives and testing for many STIs doesn't require pelvic
exams or cervical cancer screening, the researchers note.
For the study, they examined national survey data collected from
3,410 women ages 15 to 20 between 2011 and 2017.
About 23% women reported having a manual internal pelvic exam in the
previous year, translating into approximately 2.6 million young
women nationwide.
More than half of these pelvic exams - about 54% - did not appear to
have medical reasons like pregnancy, STI symptoms or use of an
intrauterine contraceptive device (IUD). This means approximately
1.4 million teens and young women may have had unnecessary exams.
[to top of second column] |
In addition, about 19% of the women said they had cervical cancer
screening with a Pap test in the previous year, translating into 2.2
million nationwide. Pap tests are only recommended for a small
minority of women under 21 who are HIV-positive and sexually active,
suggesting most of these tests were also unnecessary.
"Recommendations and guidelines have evolved over time," Qin noted.
"Prior to 2012, guidelines recommended starting cervical cancer
screening at or around onset of sexual activity or age 21, whichever
came first. In 2012, recommendations from major organizations agreed
that the initiation age (should) be 21 years regardless of sexual
behaviors and risk factors. Leading professional organizations have
issued or updated their recommendations regarding pelvic examination
since 2014, recommending against pelvic examination among women who
are not pregnant or have no symptoms."
However, she added, "many healthcare professionals still believe
that the pelvic examination is a useful tool to screen for
gynecologic cancers, contrary to guideline recommendations."
Even when women don't think they need pelvic exams or Pap tests,
they should still get annual checkups, said Dr. Melissa Simon of the
Northwestern University Feinberg School of Medicine in Chicago, who
wrote a commentary accompanying the study.
Women should ask questions before consenting to these tests and
consider switching providers if they're told they can't get birth
control without a pelvic exam, Simon said by email.
"In the absence of any symptoms or other diseases such as being
immunocompromised - like having HIV, AIDS or cancer) - a pap test is
not needed prior to age 21," Simon said.
"Also, a pelvic exam is not needed," Simon added. "And, neither a
pelvic exam nor a pap test is needed in order to obtain
contraception, except in the case (of) an IUD."
SOURCE: https://bit.ly/2FrZia6 and https://bit.ly/39IyrEl JAMA
Internal Medicine, online January 6, 2019.
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|